US Stock MarketDetailed Quotes

ERNA Eterna Therapeutics

Watchlist
  • 1.790
  • +0.054+3.12%
Close Apr 26 16:00 ET
  • 1.770
  • -0.020-1.11%
Post 19:29 ET
9.68MMarket Cap-438P/E (TTM)

Eterna Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Eterna Therapeutics Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

--

Revenue(YoY)

17.00K

0.00%
EPS(YoY)

-1.14

+8.06%
Analyst Rating

No Data

Eterna Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
--2022/Q10.000 / 0.000--
Apr 15, 20222021/Q40.000 / 0.000--
--2021/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
--2022/Q10.000 / 0.000--
Apr 15, 20222021/Q40.000 / 0.000--
--2021/Q30.000 / 0.000--

Eterna Therapeutics Earnings Reports

  • Eterna Therapeutics | 10-K/A: Annual report (Amendment)

    Mar 18 19:34

  • Eterna Therapeutics | 10-K: Annual report

    Mar 15 04:41

  • Eterna Therapeutics: Q3 2023 Earnings Report

    Nov 13, 2023 21:30

  • Eterna Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 12, 2023 04:11

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg